The present application describes methods for treating cancer with anti-ErbB2 antibodies, such as humanized anti-ErbB2 antibodies, and chemotherapeutic agents.

 
Web www.patentalert.com

< Pharmaceutical formulation comprising lanthanum compounds

> Method of reducing the risk of bone fracture
~ 00496